Journal for ImmunoTherapy of Cancer (Nov 2023)

776 Long-term efficacy and safety of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: a 4-year analysis of the C-144–01 study

  • James Larkin,
  • Harriet Kluger,
  • Omid Hamid,
  • Jeffrey Weber,
  • Amod A Sarnaik,
  • Brian Gastman,
  • Jeffrey Chou,
  • John M Kirkwood,
  • Eric Whitman,
  • Martin Wermke,
  • Evidio Domingo-Musibay,
  • Theresa Medina,
  • Sajeve Thomas,
  • Wen Shi,
  • Xiao Wu,
  • Jason A Chesney,
  • Giri Sulur,
  • Friedrich Graf Finckenstein

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0776
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.